Replies to post #5308 on $Amazing $Biotech & $olid $Microcap $tocks

[bigcat2]

NURO - But they used/lost 3.5 million in Q3. What will they lose/use in Q4? Started Q4 with 4 mil in cash.

Are they supposed to start turning a profit soon? If not they will have to raise more cash in the next month or two, right?

[ash111]

NURO 1.99 13% pm activity which is pretty rare for her. Link back to DD

[ash111]

NURO NeuroMetrix Shares Up 6.29%; Earlier 13G/A Filing Showed Sabby Management Raised Stake In Co. From 93.561K Shares To 211.908K Shares Or 9.03% https://www.benzinga.com/news/18/01/10989218/neurometrix-shares-up-6-29-earlier-13ga-filing-showed-sabby-management-raised-st

shares will be hard to get soon,post 14 insiders buy transactions, inst. following. 2.3M O/S.

link back to DD

[ash111]

NURO Great Results: NeuroMetrix Reports Preliminary 2017 Financial Highlights https://app.stockboard.com/discover/company/neurometrix-inc/release/neurometrix-reports-preliminary-2017-financial-highlights

Great results. over 40% revenue increase. Yearly revenues alone 4 times current cap. Expansions remains low indicates high profit Margin( zero debt). We might see another boost the coming months thru third generation Quell device will be launched. CNBC also following this Company. A strong buy even at a double PPS which represents only $8m MC.

Thats why the rare insiders buy transaction which i mentioned in my DD ( link back) and the new stake past week. W